FTC sues to block Surmodics acquisition by private equity over device coating competition
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with over 50% of the hydrophilic coating market.
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with over 50% of the hydrophilic coating market.
